Sr. ADME and Quantitative Pharmacology Director
Enveda · Remote, United States
Bio & Science AIremotedirector$340k–$390k
At a glance
Highlights
- Lead DMPK and PK/PD strategy from candidate nomination through clinic.
- Transform natural compounds into life-changing medicines with AI-enabled discovery.
- Drive three oral clinical programs including Phase 2 ENV-294 for eczema and asthma.
Ideal candidate
Curious, innovation-driven leader passionate about translating natural products into medicines. You thrive owning DMPK strategy end-to-end and shaping integrated development in a fast-moving biotech.
- remote policy
- remote
Lab profile
About Enveda
Clinical-stage AI-enabled biotech discovering first-in-class oral small-molecule medicines from nature.
What they build
- First-in-class oral small-molecule medicines
- Immuno-inflammation pipeline including IBD
Known for
- AI-enabled discovery from natural products
- Machine learning for mass spectrometry
- Medicinal chemistry and lead optimization
- ADME, DMPK and quantitative pharmacology
Key facts
- Clinical-stage biotech
Posted · Last seen